April 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
Cell Dissociation Market (By Product: Enzymatic Dissociation, Non-enzymatic dissociation, Instruments & Accessories; By Type: Tissue Dissociation, Cell Detachment; By End-use: Pharmaceutical & Biotechnology Companies, Research & Academic Institutes; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) G...
April 21, 2026
According to market projections, the preclinical CRO sector is expected to grow from USD 6.25 billion in 2024 to USD 14.34 billion by 2034, reflecting a CAGR of 8.73%. In 2024, North America led the preclinical CRO market with a 48% share, while Asia Pacific is set for the fastest growth through 2034. Toxicology testing dominated by service, while ...
April 21, 2026
Market insights predict the global industrial microbiology industry will increase from USD 12.75 billion in 2024 to USD 24.92 billion by 2034, achieving a CAGR of 6.93%. In 2024, North America led the industrial microbiology market with a 47% share, while Asia Pacific is set for the fastest growth. Reaction consumables dominated by product, but equ...
April 21, 2026
The global cell culture media market, valued at USD 6.9 billion in 2024, is anticipated to reach USD 20.32 billion by 2034, growing at a CAGR of 11.45% over the next decade. In 2024, North America led the global cell culture media market, while Asia-Pacific is set for the fastest growth. Liquid media and serum-free media held the largest shares. Bi...
April 21, 2026
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseas...
April 21, 2026
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America poised for strong growth. Semi-solid formulations and contract manufacturing dominated, while liquid...
April 21, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
April 21, 2026
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for the fastest growth. Contract manufacturing dominated by service, while contract development is set ...
April 21, 2026
According to forecasts, the global active pharmaceutical ingredients CDMO market will grow from USD 127.45 billion in 2024 to USD 260.98 billion by 2034, with an expected CAGR of 7.43%. In 2024, Asia-Pacific led the global API market, while North America is set for strong CDMO growth. Traditional APIs and synthetic synthesis dominated, but antibody...
April 21, 2026
According to forecasts, the global fertility market will grow from USD 36.57 billion in 2024 to USD 87.05 billion by 2034, with an expected CAGR of 9.06%. In 2024, Europe led the global fertility market share by 34%, while Asia-Pacific is set for the fastest growth ahead. Assisted reproductive technology dominated by offerings, while fertility drug...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com